(19)
(11) EP 1 357 898 A2

(12)

(88) Date of publication A3:
24.04.2003

(43) Date of publication:
05.11.2003 Bulletin 2003/45

(21) Application number: 02723104.2

(22) Date of filing: 08.02.2002
(51) International Patent Classification (IPC)7A61K 9/14, A61K 9/16, A01N 33/02
(86) International application number:
PCT/US0203/523
(87) International publication number:
WO 0206/2299 (15.08.2002 Gazette 2002/33)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 08.02.2001 US 267456 P
08.02.2001 US 267457 P

(71) Applicant: ANDRX Pharmaceuticals, Inc.
Davie, FL 33314 (US)

(72) Inventors:
  • LI, Boyong
    Davie, FL 33314 (US)
  • CHEN, Chih-Ming
    Davie, FL 33328 (US)
  • CHENG, Xiu Xiu
    Davie, FL 33328 (US)
  • NANGIA, Avinash
    Weston, FL 33327 (US)

(74) Representative: Schupfner, Georg U. et al
Müller, Schupfner & Gauger,Parkstrasse 1
21244 Buchholz
21244 Buchholz (DE)

   


(54) IMPROVED CONTROLLED RELEASE ORAL DOSAGE FORM